scholarly journals Acute Guillain-Barré Syndrome Presenting as Acute Spinal Cord Compression in an Elderly Woman

1990 ◽  
Vol 83 (5) ◽  
pp. 333-334
Author(s):  
A P Passmore ◽  
I C Taylor ◽  
J G McConnell
1994 ◽  
Vol 25 (01) ◽  
pp. 36-38 ◽  
Author(s):  
K. Gücüyener ◽  
S. Keskil ◽  
M. Baykaner ◽  
E. Bilir ◽  
A. Oğuz ◽  
...  

Author(s):  
Ozgur Deniz Sadioglu ◽  
Ozgur Sogut ◽  
Baris Agca

Abstract The management of a patient admitted to the emergency department with symptoms of Guillain–Barré syndrome (GBS), including paraplegia, who was subsequently diagnosed with Ewing sarcoma (ES) and spinal cord compression using MRI is discussed here. Pathological report confirmed the diagnosis of ES. The patient underwent immediate neurosurgery due to rapid progression of paraplegia. Keywords: Ewing sarcoma, Paraplegia, Guillain–Barré syndrome, Spinal cord compression


2020 ◽  
Vol 48 (4) ◽  
pp. 285-289
Author(s):  
A. Yu. Ryabchenko ◽  
E. V. Grankin

Guillain-Barré syndrome is an orphan autoimmune disease associated with the involvement of the peripheral nervous system. The clinical course of the syndrome has four main types. We present a clinical case of Guillain-Barré syndrome in a 6-year old child. Against the background of a previous infection, he developed oculomotor dysfunction, peripheral tetraparesis, sensory abnormalities with subsequent severe weakness of the respiratory muscles. The differential diagnosis included inflammatory, infectious and neoplastic spinal cord disorders, spinal cord magnetic resonance imaging, and examination of the cerebrospinal fluid. The patient's electromyographic data confirmed peripheral nerve damage. Based on all of these, the patient was diagnosed with Guillain-Barré syndrome. Specific treatment, including plasmapheresis and intravenous human immunoglobulin G at a dose of 0.4 mg daily for 5 days, and symptomatic treatment resulted in gradual improvement and complete regression of the neurological symptoms completely resolved. Since Guillain-Barré syndrome is a rare disease of the peripheral nervous system, the awareness of the specifics of its clinical course allows for earlier correct diagnosis and effective treatment.


Neurology ◽  
2015 ◽  
Vol 84 (5) ◽  
pp. e30-e30 ◽  
Author(s):  
C. Gachter ◽  
J. A. Petersen ◽  
U. Schwarz ◽  
A. Pangalu ◽  
A. A. Tarnutzer

Author(s):  
Roshani Dhanvijay ◽  
Ruchira Ankar

Introduction: Guillain-Barré syndrome (GBS) is a rare neurodegenerative condition in which the immune system of the body mistakenly damages a portion of the peripheral nerve system. The initial signs are general weakness and numbness in the limbs. Initial symptoms occur within a few days or weeks of infection. These symptoms can spread fast, ultimately paralyzing the entire body. The peripheral system consists of the brain and spinal cord.  The nerve network is found outside of the brain and spinal cord. GBS can range from a minor case with short weakness to a completely fatal paralysis that renders the individual unable to breathe on their own. Fortunately, even the most severe instances of GBS may be recovered from. Some people will remain feeble even after they have recovered. The majority of patients reach the peak of their weakness within the first two weeks of symptoms appearing; by the third week, 90 percent of those affected are at their weakest. Symptoms of muscle weakness include difficulty with muscles of the eyes and vision, swallowing difficulties, difficulty in speaking, or chewing, pricking or pins and needles sensations in the hands and feet, pain that can be severe, especially at night, coordination problems, and unsteadiness, abnormal heartbeat/rate or blood pressure, problems with digestion and/or bladder control, and problems with digestion and/or bladder control. Background: Guillain-Barré syndrome can affect anyone. It can attack at any age (though it is more common in adults and the elderly), and both sexes are equally susceptible to the condition. GBS is predicted to afflict one in every 100,000 people each year. GBS affects between 3,000 and 6,000 persons in the United States each year. Case Presentation: A 53 years old male patient came to the hospital with the chief complaint of weakness in all four limbs for 6 days. A patient was apparently alright 6 days back later he was experience weakness in the left side of the body following covid vaccination on 4th June, weakness was gradually progressive in nature and progress to the right side of the body after 2 days. Later on, 8th of June patient got admitted to GMC yavatmal where the routine investigation was done including a CT scan brain which normal and doctors ask for an MRI brain for which the patient and his relative had taken a DAMA discharge and brought the patient to AVBR Hospital. All investigation has been done after that the physician diagnosed the patient having Guillain barre syndrome. The patient weakness has been worse and the treatment start according to the disease condition. Medical treatment including physical therapy also been started to reducing physical weakness and the patient condition is improved day by day. Intervention: The intervention was given to the patient such as injection ceftriaxone 1 gm BD, Inj pan 40 mg OD, Inj Emset 4 mg  TDS, Inj optinurone 1 Amp in 100 ml normal saline.


Sign in / Sign up

Export Citation Format

Share Document